Continued Access to the Endogenex System for Participants in the ReCET Pivotal Study

NANot yet recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

October 31, 2027

Study Completion Date

October 31, 2027

Conditions
Type 2 Diabetes MellitusType2diabetesDiabetes Mellitus, Type 2Type 2 DiabetesDiabetes
Interventions
DEVICE

Endogenex System

The Endogenex System procedure utilizes a catheter to deliver non-thermal pulsed electric field to the first portion of the small intestine (duodenum) to induce cell regeneration. The catheter is introduced to the duodenum through the mouth using a guide wire and the therapy is applied to treat the duodenum.

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Endogenex, Inc.

INDUSTRY